AstraZeneca AB

Sweden


 
Total IP 3,055
Total IP incl. subs 3,055 (+ 0 for subs)
Total IP Rank # 369
IP Activity Score 3.7/5.0    1,131
IP Activity Rank # 631
Parent Entity AstraZeneca PLC
Dominant Nice Class Pharmaceutical, veterinary and s...

Patents

Trademarks

426 126
211 181
1,575 125
411
 
Last Patent 2024 - Pharmaceutical process and inter...
First Patent 1979 - Gastric acid secretion inhibitin...
Last Trademark 2024 - CHARGIFY
First Trademark 1950 - ASTRA

Subsidiaries

1 subsidiaries with IP (0 patents, 0 trademarks)

 Register for free to unlock the subsidiary list

Industry (Nice Classification)

Latest Inventions, Goods, Services

2024 G/S Pharmaceutical preparations and substances.
G/S Pharmaceutical preparations and substances for use in oncology.
G/S Pharmaceutical preparations and substances for the treatment of immune-mediated inflammatory dise...
G/S Pharmaceutical preparations and substances for use in oncology
G/S Pharmaceutical preparations and substances
2023 G/S Pharmaceutical preparations and substances for the treatment of amyloidosis.
G/S Pharmaceutical preparations and substances for the treatment of amyloidosis.
Invention Methods of treating heart failure with preserved ejection fraction employing dapagliflozin and co...
Invention Pharmaceutical composition. The invention concerns pharmaceutical compositions containing a hydr...
G/S Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and s...
G/S Pharmaceutical preparations and substances for the treatment of amyloidosis.
G/S Pharmaceutical preparations and substances. Medical devices, namely, inhalers.
G/S Pharmaceutical preparations and substances.
Invention Chemical compounds. The present invention relates to azaquinolone compounds of Formula (I), and ...
Invention Compositions and methods for treating advanced solid tumors. Disclosed are methods for treating s...
Invention Combination of sglt2 inhibitors and mineralcorticoid receptor modulators for use in treatment of ...
Invention Pharmaceutical formulations. A pharmaceutical formulation which comprises Compound 1, one or mor...
Invention Pharmaceutical formulation. A pharmaceutical formulation which comprises Compound 1, one or more ...
Invention Process for the preparation of substituted pyrrolopyrimidines and intermediates. There is provide...
Invention Pharmaceutical process and intermediates. There is provided a new and improved synthetic route f...
Invention Inhibitors of myeloperoxidase. The specification generally relates to compounds of Formula (I), (...
Invention Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides for treating bronchiecta...
Invention Mta-cooperative prmt5 inhibitors for use in the treatment of cancer. MTAPMTAP gene cancers compri...
Invention Combination therapies for treatment of cirrhosis with portal hypertension. A method of treating ...
Invention Combination therapies for treatment of cirrhosis with portal hypertension. Composition comprising...
Invention Methods for detecting metabolites using a microfluidic-based ce-ms system. The present disclosure...
Invention Combinations of recombinant virus expressing interleukin-12 with pd-1/pd-l1 inhibitors. The prese...
Invention Combination treatment. The present invention relates to methods for treating ischemic events in ...
Invention Pcsk9 inhibitors and methods of use thereof. Disclosed herein are PCSK9 inhibitors. Also disclose...
Invention Epidermal growth factor receptor tyrosine kinase inhibitors in combination with hgf-receptor inhi...
Invention Treatment for immuno-oncology resistant subjects with an anti pd-l1 antibody an antisense targete...
Invention Anti-pcrv and psl bispecific antibodies for treatment of bronchiectasis. PseudomonasPseudomonas P...
Invention Combinations involving epidermal growth factor receptor tyrosine kinase inhibitors for the treatm...
G/S Pharmaceutical preparations and substances for the treatment of amyloidosis
Invention N-(2-(4-cyanothiazolidin-3-yl)-2-oxoethyl)- 6-morpholinoquinoline-4-carboxamide. NN-(2-(4-cyanoth...
Invention N-(2-(3-cyano-2-azabicyclo[3.1.0]hexan-2-yl)-2-oxoethyl)- quinoline-4-carboxamides. Compounds hav...
Invention N-(2-(4-cyanothiazolidin-3-yl)-2-oxoethyl)- quinoline-4-carboxamides. Compounds having the struct...
Invention N-(2-(3-cyano-2-azabicyclo[3.1.0]hexan-2-yl)-2-oxoethyl)quinoline-4-carboxamides. Compounds havi...
Invention Combination therapy for treating cancer. The present provides a method of treating ovarian cancer...
Invention Systems and methods for end to end continuous downstream processing. Provided herein are methods ...
Invention Methods for unified concentration and buffer exchange. Provided herein are methods of purifying p...
Invention Recombinant virus expressing interleukin-12. The present disclosure relates to a recombinant poxv...
Invention Rxfp1 modulators for treating resistant hypertension or heart failure with pulmonary hypertension...
Invention Solid forms of rxfp1 modulators. The specification generally relates to solid forms, for example,...
Invention Combinations of rxfp1 modulators and sglt2 inhibitors. The specification generally relates to com...
Invention Solid forms of heterocyclylamides as irak4 inhibitors. The present specification relates to novel...
Invention Gene therapy compositions and methods of use thereof. Presented herein are compositions and metho...
Invention Predicting disease progression in portal hypertension using machine learning. An example embodime...
Invention Amino heteroaromatic compounds useful in the treatment of liver diseases. The specification relat...
Invention Predicting albuminuria using machine learning. An example embodiment may involve obtaining, by a ...
Invention Pcsk9 inhibitors and methods of use thereof. The invention relates to a novel inhibitor pharmaco...
2022 G/S Pharmaceutical preparations for use in oncology; Pharmaceutical preparations and substances for t...
Invention Methods of treating melanoma using tebentafusp and immune checkpoint inhibitors. The present inve...
Invention Methods for treating small cell lung cancer and other neuroendocrine cancers. The current disclo...
Invention New method to pronostic lung cancer. The present invention relates to the field of prognostic of...
Invention Graph construction and visualization of multiplex immunofluorescence images. Provided herein are...
2021 Invention Oral formulation of a therapeutic compound. The present invention provides a pharmaceutical tabl...
Invention Automated assessment of wound tissue. A method of assessing a wound in a subject is provided. Th...
Invention Adjuvant durvalumab in combination with chemotherapy for treatment of cancer. The disclosure gen...
Invention Treatment of flares in lupus. The disclosure relates to methods and compositions for the treatme...
Invention Biomarkers for predicting overall survival in recorrent/metastatic head and neck squamous cell ca...